3 resultados
FIELD
The present invention relates to compounds by the regulation of cannabinoid receptors. More specifically, the compounds are inverse antagonists of cannabinoid receptor subtype-2, otherwise known as CB2.
BACKGROUND
Osteoporosis is a major metabolic bone disease that affects 44 million Americans
FIELD
The present invention relates to compounds by the regulation of cannabinoid receptors. More specifically, the compounds are inverse antagonists of cannabinoid receptor subtype-2, otherwise known as CB2.
BACKGROUND
Osteoporosis is a major metabolic bone disease that affects 44 million Americans
BACKGROUND
The field of cannabinoid research has gained attention in recent years, particularly in view of the legal use of medical marijuana now approved in several states. However, medical marijuana or cannabinoid (CB) has reached certain limitation. Cannabinoid (CB) drug research also faces a